CN109810440A - A kind of PMMA/SCTP composite fine powder and preparation method and composite bone cement using the same - Google Patents
A kind of PMMA/SCTP composite fine powder and preparation method and composite bone cement using the same Download PDFInfo
- Publication number
- CN109810440A CN109810440A CN201711236976.9A CN201711236976A CN109810440A CN 109810440 A CN109810440 A CN 109810440A CN 201711236976 A CN201711236976 A CN 201711236976A CN 109810440 A CN109810440 A CN 109810440A
- Authority
- CN
- China
- Prior art keywords
- parts
- pmma
- sctp
- powder
- composite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 43
- 229920003229 poly(methyl methacrylate) Polymers 0.000 title claims abstract description 41
- 239000004926 polymethyl methacrylate Substances 0.000 title claims abstract description 41
- 239000002639 bone cement Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 239000000843 powder Substances 0.000 title claims description 27
- 229920001577 copolymer Polymers 0.000 claims abstract description 21
- 235000019832 sodium triphosphate Nutrition 0.000 claims abstract description 11
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 claims abstract description 6
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000011258 core-shell material Substances 0.000 claims abstract description 4
- 239000000178 monomer Substances 0.000 claims description 20
- 239000003995 emulsifying agent Substances 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 239000008367 deionised water Substances 0.000 claims description 11
- 229910021641 deionized water Inorganic materials 0.000 claims description 11
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical class [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 239000003431 cross linking reagent Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- -1 neopelex Chemical compound 0.000 claims description 7
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- 239000001110 calcium chloride Substances 0.000 claims description 5
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 claims description 4
- 239000004342 Benzoyl peroxide Substances 0.000 claims description 4
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 claims description 4
- 235000019400 benzoyl peroxide Nutrition 0.000 claims description 4
- 239000003999 initiator Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- UACSZOWTRIJIFU-UHFFFAOYSA-N hydroxymethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCO UACSZOWTRIJIFU-UHFFFAOYSA-N 0.000 claims description 2
- GJIDOLBZYSCZRX-UHFFFAOYSA-N hydroxymethyl prop-2-enoate Chemical group OCOC(=O)C=C GJIDOLBZYSCZRX-UHFFFAOYSA-N 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- GYVGXEWAOAAJEU-UHFFFAOYSA-N n,n,4-trimethylaniline Chemical group CN(C)C1=CC=C(C)C=C1 GYVGXEWAOAAJEU-UHFFFAOYSA-N 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims 2
- 229940063557 methacrylate Drugs 0.000 claims 2
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- 239000003643 water by type Substances 0.000 claims 2
- ZMAPSRURQKEIRJ-UHFFFAOYSA-N 3-hydroxy-2-methylhept-2-enoic acid Chemical compound CCCCC(O)=C(C)C(O)=O ZMAPSRURQKEIRJ-UHFFFAOYSA-N 0.000 claims 1
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims 1
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 claims 1
- AMFGWXWBFGVCKG-UHFFFAOYSA-N Panavia opaque Chemical compound C1=CC(OCC(O)COC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OCC(O)COC(=O)C(C)=C)C=C1 AMFGWXWBFGVCKG-UHFFFAOYSA-N 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 239000005864 Sulphur Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229910052788 barium Inorganic materials 0.000 claims 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims 1
- 230000001804 emulsifying effect Effects 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229940093476 ethylene glycol Drugs 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000009413 insulation Methods 0.000 claims 1
- 235000019394 potassium persulphate Nutrition 0.000 claims 1
- 239000001384 succinic acid Substances 0.000 claims 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 claims 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
- 239000004005 microsphere Substances 0.000 abstract description 23
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 12
- 239000001506 calcium phosphate Substances 0.000 description 11
- 229910000389 calcium phosphate Inorganic materials 0.000 description 11
- 235000011010 calcium phosphates Nutrition 0.000 description 10
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 6
- 239000002245 particle Substances 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 4
- 238000004626 scanning electron microscopy Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000005138 cryopreservation Methods 0.000 description 2
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- HXCWOOAEAHVMBJ-UHFFFAOYSA-N 2-(n,4-dimethylanilino)ethanol Chemical compound OCCN(C)C1=CC=C(C)C=C1 HXCWOOAEAHVMBJ-UHFFFAOYSA-N 0.000 description 1
- IEVADDDOVGMCSI-UHFFFAOYSA-N 2-hydroxybutyl 2-methylprop-2-enoate Chemical compound CCC(O)COC(=O)C(C)=C IEVADDDOVGMCSI-UHFFFAOYSA-N 0.000 description 1
- ABPJHHHWWYDYFZ-UHFFFAOYSA-N 2-methylidenebutanedioic acid;prop-2-enoic acid Chemical compound OC(=O)C=C.OC(=O)CC(=C)C(O)=O ABPJHHHWWYDYFZ-UHFFFAOYSA-N 0.000 description 1
- NDWUBGAGUCISDV-UHFFFAOYSA-N 4-hydroxybutyl prop-2-enoate Chemical compound OCCCCOC(=O)C=C NDWUBGAGUCISDV-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- 102000008143 Bone Morphogenetic Protein 2 Human genes 0.000 description 1
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
- YZYASTRURKBPPS-UHFFFAOYSA-N C(CCC(=O)OCCCCCC(C)C)(=O)OCCCCCC(C)C.[Na] Chemical compound C(CCC(=O)OCCCCCC(C)C)(=O)OCCCCCC(C)C.[Na] YZYASTRURKBPPS-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- BAPJBEWLBFYGME-UHFFFAOYSA-N acrylic acid methyl ester Natural products COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- 238000010883 osseointegration Methods 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 1
- 238000003746 solid phase reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及一种具有核壳结构的PMMA/SCTP复合微粉,核是甲基丙烯酸甲酯共聚物(PMMA),壳是三聚磷酸钙钠(SCTP)。所述复合微球的制备步骤是先制备共聚物微球,然后在模板剂的作用下将三聚磷酸钙钠在共聚物微球表面进行沉积、包覆,得到PMMA/SCTP复合微粉。将所述复合微粉用于配制复合型骨水泥。The invention relates to a PMMA/SCTP composite micropowder with a core-shell structure. The core is methyl methacrylate copolymer (PMMA) and the shell is sodium calcium tripolyphosphate (SCTP). The preparation steps of the composite microspheres are to prepare the copolymer microspheres first, and then deposit and coat the sodium calcium tripolyphosphate on the surface of the copolymer microspheres under the action of the template agent to obtain the PMMA/SCTP composite micropowder. The composite micropowder is used to prepare composite bone cement.
Description
技术领域technical field
本发明涉及一种具有核壳结构的有机/无机纳米粉末,具体地涉及一种PMMA/SCTP复合微粉以及所述复合微粉的制备方法和应用其制备的复合型骨水泥。The invention relates to an organic/inorganic nano-powder with a core-shell structure, in particular to a PMMA/SCTP composite fine powder, a preparation method of the composite fine powder, and a composite bone cement prepared by using the same.
背景技术Background technique
骨水泥是一种用于填充骨或植入骨间隙或骨腔并具有自凝特性的生物材料。骨水泥主要有聚甲基丙烯酸甲酯(PMMA)骨水泥和磷酸钙类骨水泥两种。其中,PMMA骨水泥在临床上取得了良好的应用效果,但PMMA本身是生物惰性的,不能与骨组织结合。相反,磷酸钙类骨水泥具有生物相容性、生物降解性,在组成方面接近于骨组织,可以促进骨结合、细胞粘附和新骨形成。Bone cement is a biomaterial that is used to fill bone or implant into bone spaces or cavities and has self-coagulating properties. Bone cement mainly includes polymethyl methacrylate (PMMA) bone cement and calcium phosphate bone cement. Among them, PMMA bone cement has achieved good clinical application results, but PMMA itself is biologically inert and cannot be combined with bone tissue. In contrast, calcium phosphate-based bone cements are biocompatible, biodegradable, close to bone tissue in composition, and can promote osseointegration, cell adhesion, and new bone formation.
专利CN1927416涉及一种复合多孔磷酸钙骨水泥及其制备方法。该骨水泥由磷酸钙骨水泥固相粉末与经过60Co射线辐照处理的3-羟基丁酸-co-3-羟基戊酸共聚物(PHBV)微球与固化液组成。专利CN101716379涉及包括固相和液相的双固化复合磷酸钙骨水泥,固相包含磷酸钙骨水泥粉末和氧化剂;液相包含去离子水、水溶性可交联聚合物、还原剂。专利CN1821143提供一种磷酸钙骨水泥复合材料的制备方法。(1)磷酸钙、碳酸钙和磷酸氢钙经高温固相反应合成仅含有羟基磷灰石和α-磷酸三钙的粉剂,粉末按重量比2∶1掺入蔗糖晶体混匀,作为固相;(2)配制丙烯酸-衣康酸共聚液,作为液相;(3)按重量比3∶1称取固相和液相,混合,填入模具成形,在磷酸钙骨水泥调和过程中在每个模具中掺入人类基因重组骨形成蛋白-2,即可得到复合BMP-2的磷酸钙骨水泥材料。Patent CN1927416 relates to a composite porous calcium phosphate bone cement and its preparation method. The bone cement is composed of calcium phosphate bone cement solid phase powder, 3-hydroxybutyric acid-co-3-hydroxyvaleric acid copolymer (PHBV) microspheres and curing liquid treated with 60Co rays. Patent CN101716379 relates to a dual-curing composite calcium phosphate bone cement including a solid phase and a liquid phase. The solid phase includes calcium phosphate bone cement powder and an oxidizing agent; the liquid phase includes deionized water, a water-soluble cross-linkable polymer, and a reducing agent. Patent CN1821143 provides a preparation method of calcium phosphate bone cement composite material. (1) Calcium phosphate, calcium carbonate and calcium hydrogen phosphate are synthesized by high-temperature solid-phase reaction to synthesize powder containing only hydroxyapatite and α-tricalcium phosphate. (2) prepare acrylic acid-itaconic acid copolymerization liquid, as liquid phase; (3) take solid phase and liquid phase by weight ratio 3: 1, mix, fill in mould forming, in calcium phosphate bone cement reconciling process in The human gene recombinant bone morphogenetic protein-2 is incorporated into each mold to obtain a calcium phosphate bone cement material compounded with BMP-2.
专利CN105315478涉及一种用纳米磷酸钙涂覆聚甲基丙烯酸甲酯(PMMA)为基底的共聚物及其包覆方法。方法包括合成含羟基侧基的PMMA为基底的共聚物微球,使钙盐和磷酸溶液与PMMA为基底的共聚物微球上的羟基侧基反应,以及使PMMA为基底的聚合物微球上的纳米磷酸钙涂覆物增厚。Patent CN105315478 relates to a kind of copolymer with nano-calcium phosphate coating polymethyl methacrylate (PMMA) as the base and its coating method. The method includes synthesizing PMMA-based copolymer microspheres containing hydroxyl side groups, reacting calcium salt and phosphoric acid solution with the hydroxyl side groups on the PMMA-based copolymer microspheres, and making PMMA-based polymer microspheres on the PMMA-based polymer microspheres. thickening of the nanocalcium phosphate coating.
发明内容SUMMARY OF THE INVENTION
本发明提供了一种PMMA/SCTP复合微粉,所述复合微粉具有核壳结构,所述核是甲基丙烯酸甲酯(MMA)与功能单体、交联剂的共聚物微球,所述壳是三聚磷酸钙钠(SCTP)。The invention provides a PMMA/SCTP composite micropowder, the composite micropowder has a core-shell structure, the core is a copolymer microsphere of methyl methacrylate (MMA), a functional monomer and a cross-linking agent, and the shell is It is sodium calcium tripolyphosphate (SCTP).
另一方面,本发明提供了一种用SCTP包覆PMMA共聚物微球的方法。首先合成PMMA共聚物微球,然后让氯化钙和三聚磷酸钠盐反应,并在模板剂的作用下聚集并包覆在PMMA共聚物微球上,得到PMMA/SCTP复合微粉。In another aspect, the present invention provides a method for coating PMMA copolymer microspheres with SCTP. Firstly, PMMA copolymer microspheres are synthesized, and then calcium chloride and sodium tripolyphosphate are reacted, and aggregated and coated on PMMA copolymer microspheres under the action of a template to obtain PMMA/SCTP composite micropowders.
再者,本发明提供了一种应用所述PMMA/SCTP复合微粉的复合型骨水泥。Furthermore, the present invention provides a composite bone cement using the PMMA/SCTP composite fine powder.
本发明所述的一种PMMA/SCTP复合微粉,其制备方法包括以下步骤:A kind of PMMA/SCTP composite micropowder of the present invention, its preparation method comprises the following steps:
(1)配制复合乳化剂,配制混合单体,同时配制浓度为0.1%~10%的过硫酸钾水溶液;(1) Prepare a composite emulsifier, prepare a mixed monomer, and at the same time prepare an aqueous potassium persulfate solution with a concentration of 0.1% to 10%;
所述复合乳化剂包括十二烷基硫酸钠、十二烷基磺酸钠、十二烷基苯磺酸钠、琥珀酸二异辛酯基磺酸钠、OP系列乳化剂、Tween系列乳化剂、Span系列乳化剂、聚乙烯醇、羧甲基纤维素中的一种或任意组合;The composite emulsifier includes sodium dodecyl sulfate, sodium dodecyl sulfonate, sodium dodecyl benzene sulfonate, sodium diisooctyl succinate, OP series emulsifier, Tween series emulsifier , one or any combination of Span series emulsifier, polyvinyl alcohol, carboxymethyl cellulose;
所述混合单体包括甲基丙烯酸甲酯、功能单体和交联剂,其中甲基丙烯酸甲酯、功能单体、交联剂的重量比是1∶0.05~0.2∶0.001~0.1;The mixed monomer includes methyl methacrylate, functional monomer and cross-linking agent, wherein the weight ratio of methyl methacrylate, functional monomer and cross-linking agent is 1:0.05-0.2:0.001-0.1;
所述功能单体是羟甲基丙烯酸酯、羟乙基丙烯酸酯、羟丙基丙烯酸酯、羟丁基丙烯酸酯、羟甲基甲基丙烯酸酯、羟乙基甲基丙烯酸酯、羟丙基甲基丙烯酸酯、羟丁基甲基丙烯酸酯、中的一种或任意组合,所述交联剂是双甲基丙烯酸二缩三乙二醇酯、双酚A-双甲基丙烯酸缩水甘油酯中的一种;The functional monomers are hydroxymethyl acrylate, hydroxyethyl acrylate, hydroxypropyl acrylate, hydroxybutyl acrylate, hydroxymethyl methacrylate, hydroxyethyl methacrylate, hydroxypropyl methyl acrylate One or any combination of base acrylate, hydroxybutyl methacrylate, and the crosslinking agent is one of triethylene glycol bismethacrylate, bisphenol A-glycidyl bismethacrylate. kind;
(2)向反应釜中依次加入100份去离子水、0.5份~10份复合乳化剂、6份~30份混合单体,同时升温和乳化,充氮保护;升温至80℃后,加入0.1份~1份过硫酸钾水溶液,反应15min~60min后,在2h~3h内同时匀速滴加20份~90份混合单体和0.1份~2份过硫酸钾溶液;滴加完后,继续保温反应2h~3h;降温至室温,进行多次离心分离、去离子水冲洗循环,得到甲基丙烯酸甲酯共聚物微球;(2) Add 100 parts of deionized water, 0.5 to 10 parts of composite emulsifier, and 6 to 30 parts of mixed monomers in sequence into the reactor, heat up and emulsify at the same time, and protect with nitrogen; Part to 1 part of potassium persulfate aqueous solution, after 15min to 60min of reaction, 20 to 90 parts of mixed monomer and 0.1 to 2 parts of potassium persulfate solution are added dropwise at the same time within 2h to 3h; after the dropwise addition, continue to keep warm The reaction is carried out for 2h to 3h; the temperature is lowered to room temperature, and several cycles of centrifugal separation and deionized water washing are carried out to obtain methyl methacrylate copolymer microspheres;
所述甲基丙烯酸甲酯共聚物微球的直径在0.02μm~3μm之间。The diameter of the methyl methacrylate copolymer microspheres is between 0.02 μm and 3 μm.
(3)室温下,向反应釜中依次加入100份去离子水、1份~20份甲基丙烯酸甲酯共聚物微球、0.2份~4份模板剂,搅拌至溶解,用氢氧化钠调pH值到7.5~8.5;加入氯化钙水溶液,搅拌15min~45min后,按照钙元素与钠元素的摩尔比为2∶1加入三聚磷酸钠水溶液,反应0.3h~2h,陈化1h~2h,过滤,乙醇洗涤,冻干,得到PMMA/SCTP复合微粉;(3) At room temperature, add 100 parts of deionized water, 1 to 20 parts of methyl methacrylate copolymer microspheres, and 0.2 to 4 parts of templating agent in sequence, stir until dissolved, adjust with sodium hydroxide pH value reaches 7.5~8.5; add calcium chloride aqueous solution, after stirring for 15min~45min, add sodium tripolyphosphate aqueous solution according to the molar ratio of calcium element and sodium element as 2:1, react for 0.3h~2h, and age for 1h~2h , filtered, washed with ethanol, and freeze-dried to obtain PMMA/SCTP composite micropowder;
所述模板剂是酪氨酸、甘氨酸、天冬氨酸、谷氨酸、6-氨基己酸、麦芽糖糊精、乙二胺四乙酸、乙二胺四乙酸二钠、乙二胺四乙酸四钠中的一种;The templating agent is tyrosine, glycine, aspartic acid, glutamic acid, 6-aminocaproic acid, maltodextrin, EDTA, disodium EDTA, EDTA tetra a type of sodium;
所述的PMMA/SCTP复合微粉粒径在0.02μm~200μm之间;三聚磷酸钙钠还可以继续在微球表面沉积。The particle size of the PMMA/SCTP composite micropowder is between 0.02 μm and 200 μm; and the sodium calcium tripolyphosphate can continue to be deposited on the surface of the microsphere.
用所述的PMMA/SCTP复合微粉配制一种复合型骨水泥。所述复合型骨水泥由粉体部分和液体部分组成,所述粉体部分由65份~75份所述的PMMA/SCTP复合微粉、0.1份~3份引发剂和24份~32份硫酸钡混合均匀而成,所述液体部分由90份~99.5份甲基丙烯酸甲酯、0.5份~10份促进剂和60ppm~200ppm对苯二酚混合均匀而成。A composite bone cement is prepared by using the PMMA/SCTP composite fine powder. The composite bone cement is composed of a powder part and a liquid part, and the powder part consists of 65 to 75 parts of the PMMA/SCTP composite micropowder, 0.1 to 3 parts of an initiator and 24 to 32 parts of barium sulfate The liquid part is uniformly mixed by mixing 90 to 99.5 parts of methyl methacrylate, 0.5 to 10 parts of an accelerator and 60 to 200 ppm of hydroquinone.
所述引发剂是过氧化苯甲酰、过氧化二月桂酰中的一种;Described initiator is a kind of in benzoyl peroxide, dilauroyl peroxide;
所述促进剂是N,N-二甲基-对-甲苯胺、N,N-二甲基苯胺、N-甲基-N-(2-羟乙基)-对-甲苯胺中的一种。Described accelerator is a kind of in N,N-dimethyl-p-toluidine, N,N-dimethylaniline, N-methyl-N-(2-hydroxyethyl)-p-toluidine .
所述粉体部分和所述液体部分经过无菌处理后分别封装在无菌容器中,使用前按照粉体部分与液体部分的重量比1.5~4∶1进行混合。The powder part and the liquid part are separately packaged in sterile containers after aseptic treatment, and mixed according to the weight ratio of the powder part to the liquid part of 1.5-4:1 before use.
PMMA共聚物含有亲水性的羟基,在模板剂的作用下钙离子与三聚磷酸根离子结合会沉降在PMMA共聚物微球表面,进而聚集、包覆,经分离、洗涤、冻干,形成PMMA/SCTP复合微粉。SCTP具有生物相容性和活性,作为主要成份可以赋予骨水泥生物活性。The PMMA copolymer contains hydrophilic hydroxyl groups. Under the action of the template agent, calcium ions and tripolyphosphate ions combine to settle on the surface of the PMMA copolymer microspheres, and then aggregate and coat. After separation, washing, and freeze-drying, the formation of PMMA/SCTP composite powder. SCTP has biocompatibility and activity, and as the main component, it can impart biological activity to bone cement.
具体实施例specific embodiment
实施例1Example 1
按1∶1∶0.15的重量比配制十二烷基苯磺酸钠、OP-10和聚乙烯醇的复合乳化剂;按1∶0.1∶0.02的重量比配制甲基丙烯酸甲酯、羟乙基甲基丙烯酸酯、双甲基丙烯酸二缩三乙二醇酯的混合单体;配制浓度为1%的过硫酸钾水溶液。The composite emulsifier of sodium dodecylbenzene sulfonate, OP-10 and polyvinyl alcohol was prepared according to the weight ratio of 1:1:0.15; methyl methacrylate, hydroxyethyl methacrylate were prepared according to the weight ratio of 1:0.1:0.02 Mixed monomers of methacrylate and triethylene glycol bismethacrylate; prepare a potassium persulfate aqueous solution with a concentration of 1%.
将100份去离子水、4.5份复合乳化剂、15份混合单体混合在一起,开动搅拌,同时升温,形成乳液,用氨水将pH值调到8,充氮保护;升温至80℃,15min内滴加6份过硫酸钾溶液,反应30min后,在2h内同时滴加30份混合单体和12份过硫酸钾溶液;滴加完毕后,继续保温反应3h。降至室温,进行三次离心分离、1000份去离子水洗涤循环,得到甲基丙烯酸甲酯共聚物微球。采用扫描电子显微镜技术,测得甲基丙烯酸甲酯共聚物微球平均粒径32.7nm。Mix 100 parts of deionized water, 4.5 parts of compound emulsifier, and 15 parts of mixed monomers, start stirring, and heat up at the same time to form an emulsion, adjust the pH value to 8 with ammonia water, and fill with nitrogen for protection; heat up to 80 ° C for 15 minutes 6 parts of potassium persulfate solution was added dropwise, and after 30 minutes of reaction, 30 parts of mixed monomer and 12 parts of potassium persulfate solution were added dropwise at the same time within 2 hours; after the dropwise addition, the reaction was continued for 3 hours. The temperature was lowered to room temperature, and three cycles of centrifugal separation and 1000 parts of deionized water were performed to obtain methyl methacrylate copolymer microspheres. Using scanning electron microscopy, the average particle size of the methyl methacrylate copolymer microspheres was measured to be 32.7 nm.
向反应釜中依次加入100份去离子水、5份甲基丙烯酸甲酯共聚物微球、0.5份L-谷氨酸,搅拌至溶解,用氢氧化钠调pH值到8;加入10份浓度为50%的氯化钙水溶液,搅拌20min后加入8.3份浓度为50%的三聚磷酸钠水溶液,反应1.5h,陈化1.5h,过滤,乙醇洗涤,冻干,得到PMMA/SCTP复合微粉;采用扫描电子显微镜技术,测得PMMA/SCTP复合微粉平均粒径108nm。Add 100 parts of deionized water, 5 parts of methyl methacrylate copolymer microspheres, 0.5 part of L-glutamic acid to the reaction kettle in turn, stir until dissolved, adjust the pH to 8 with sodium hydroxide; add 10 parts of concentration It was 50% calcium chloride aqueous solution, stirred for 20min, added 8.3 parts of 50% sodium tripolyphosphate aqueous solution, reacted for 1.5h, aged for 1.5h, filtered, washed with ethanol, and freeze-dried to obtain PMMA/SCTP composite micropowder; The average particle size of the PMMA/SCTP composite micropowder was measured to be 108 nm by scanning electron microscopy.
将73份PMMA/SCTP复合微粉、2份过氧化苯甲酰、25份硫酸钡混合均匀,作为粉体部分;将96.4份甲基丙烯酸甲酯(含100ppm对苯二酚)、3.6份N,N-二甲基对甲苯胺混合均匀,作为液体部分。分别进行灭菌处理,按照3∶1的比例取粉体部分和液体部分,分别保存在无菌冻存管中。Mix 73 parts of PMMA/SCTP composite micropowder, 2 parts of benzoyl peroxide, and 25 parts of barium sulfate as powder part; 96.4 parts of methyl methacrylate (containing 100ppm of hydroquinone), 3.6 parts of N, The N-dimethyl-p-toluidine was mixed well and used as the liquid part. Sterilize separately, take the powder part and the liquid part according to the ratio of 3:1, and store them in sterile cryopreservation tubes respectively.
实施例2Example 2
按1∶1.5的重量比配制十二烷基硫酸钠和Span-60的复合乳化剂;按1∶0.2∶0.01的重量比配制甲基丙烯酸甲酯、羟乙基丙烯酸酯、双甲基丙烯酸乙二醇酯的混合单体;配制浓度为1%的过硫酸钾水溶液。The composite emulsifier of sodium lauryl sulfate and Span-60 is prepared according to the weight ratio of 1:1.5; methyl methacrylate, hydroxyethyl acrylate and ethyl dimethacrylate are prepared according to the weight ratio of 1:0.2:0.01 Mixed monomer of glycol ester; prepare potassium persulfate aqueous solution with concentration of 1%.
将100份去离子水、3份复合乳化剂、5份混合单体混合在一起,开动搅拌,同时升温,形成乳液,用氨水将pH值调到8,充氮保护;升温至80℃,15min内滴加6份过硫酸钾溶液,反应30min后,在2h内同时滴加55份混合单体和10份过硫酸钾溶液;滴加完毕后,继续保温反应3h。降至室温,进行三次离心分离、1000份去离子水洗涤循环,得到甲基丙烯酸甲酯共聚物微球。采用扫描电子显微镜技术,测得甲基丙烯酸甲酯共聚物微球平均粒径0.46μm。Mix 100 parts of deionized water, 3 parts of compound emulsifier, and 5 parts of mixed monomers, start stirring, and heat up at the same time to form an emulsion, adjust the pH value to 8 with ammonia water, and fill with nitrogen for protection; heat up to 80 ° C for 15 minutes 6 parts of potassium persulfate solution was added dropwise, and after the reaction for 30 minutes, 55 parts of mixed monomers and 10 parts of potassium persulfate solution were added dropwise simultaneously within 2 hours; after the dropwise addition, the reaction was continued for 3 hours. The temperature was lowered to room temperature, and three cycles of centrifugal separation and 1000 parts of deionized water were performed to obtain methyl methacrylate copolymer microspheres. Using scanning electron microscopy, the average particle size of the methyl methacrylate copolymer microspheres was measured to be 0.46 μm.
向反应釜中依次加入100份去离子水、5份甲基丙烯酸甲酯共聚物微球、1份乙二胺四乙酸二钠,搅拌至溶解,用氢氧化钠调pH值到8;加入25份浓度为50%的氯化钙水溶液,搅拌20min后加入21份浓度为50%的三聚磷酸钠水溶液,反应2h,陈化2h,过滤,乙醇洗涤,冻干,得到PMMA/SCTP复合微粉;采用扫描电子显微镜技术,测得PMMA/SCTP复合微粉平均粒径2.59μm。Add 100 parts of deionized water, 5 parts of methyl methacrylate copolymer microspheres, and 1 part of disodium EDTA into the reaction kettle in turn, stir until dissolved, and adjust the pH to 8 with sodium hydroxide; add 25 A calcium chloride aqueous solution with a concentration of 50% was added into 21 parts of an aqueous solution of sodium tripolyphosphate with a concentration of 50% after stirring for 20 min, reacted for 2 h, aged for 2 h, filtered, washed with ethanol, and freeze-dried to obtain the PMMA/SCTP composite micropowder; Using scanning electron microscopy, the average particle size of the PMMA/SCTP composite micropowder was measured to be 2.59 μm.
将70份PMMA/SCTP复合微粉、2份过氧化苯甲酰、28份硫酸钡混合均匀,作为粉体部分;将98.1份甲基丙烯酸甲酯(含100ppm对苯二酚)、1.9份N,N-二甲基对甲苯胺混合均匀,作为液体部分。分别进行灭菌处理,按照3∶1的比例取粉体部分和液体部分,分别保存在无菌冻存管中。Mix 70 parts of PMMA/SCTP composite micropowder, 2 parts of benzoyl peroxide, and 28 parts of barium sulfate as the powder part; 98.1 parts of methyl methacrylate (containing 100ppm of hydroquinone), 1.9 parts of N, The N-dimethyl-p-toluidine was mixed well and used as the liquid part. Sterilize separately, take the powder part and the liquid part according to the ratio of 3:1, and store them in sterile cryopreservation tubes respectively.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711236976.9A CN109810440A (en) | 2017-11-21 | 2017-11-21 | A kind of PMMA/SCTP composite fine powder and preparation method and composite bone cement using the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711236976.9A CN109810440A (en) | 2017-11-21 | 2017-11-21 | A kind of PMMA/SCTP composite fine powder and preparation method and composite bone cement using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109810440A true CN109810440A (en) | 2019-05-28 |
Family
ID=66600096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711236976.9A Pending CN109810440A (en) | 2017-11-21 | 2017-11-21 | A kind of PMMA/SCTP composite fine powder and preparation method and composite bone cement using the same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109810440A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111330074A (en) * | 2020-03-20 | 2020-06-26 | 松山湖材料实验室 | Modified bone cement material and preparation method thereof |
| CN111467564A (en) * | 2020-03-25 | 2020-07-31 | 西安理工大学 | Self-expansion composite bone cement and preparation method thereof |
| CN120554786A (en) * | 2025-06-06 | 2025-08-29 | 江西京纬通新材料有限公司 | A process for synthesizing ultrafine calcium hydrogen phosphate dihydrate powder |
-
2017
- 2017-11-21 CN CN201711236976.9A patent/CN109810440A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111330074A (en) * | 2020-03-20 | 2020-06-26 | 松山湖材料实验室 | Modified bone cement material and preparation method thereof |
| CN111467564A (en) * | 2020-03-25 | 2020-07-31 | 西安理工大学 | Self-expansion composite bone cement and preparation method thereof |
| CN120554786A (en) * | 2025-06-06 | 2025-08-29 | 江西京纬通新材料有限公司 | A process for synthesizing ultrafine calcium hydrogen phosphate dihydrate powder |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105592867B (en) | Hardenable Multi-Part Acrylic Composition | |
| ES2640261T3 (en) | Hardened two part acrylic composition | |
| EP2712876B1 (en) | A hardenable two part acrylic composition | |
| US10149919B2 (en) | Hardenable multi-part acrylic composition | |
| JP2009512507A (en) | Curable bone substitute | |
| EP1687040B1 (en) | Bioresorbable composite material | |
| SE524334C2 (en) | Heat-generating biocompatible ceramic materials and processes for their preparation | |
| CN104147639A (en) | Injectable bone cement containing strontium and preparation method of bone cement | |
| CN109810440A (en) | A kind of PMMA/SCTP composite fine powder and preparation method and composite bone cement using the same | |
| KR20170096268A (en) | Acrylic bone cement composite comprising calcium phosphate microsphere uniformly spreaded therein and a preparation method thereof | |
| CN110339395B (en) | PMMA-based hydrated bone cement and preparation method and application thereof | |
| CN106139253A (en) | The compositions that can form composite bone cement and the bone cement formed by it | |
| CN105315478A (en) | Polymethyl methacrylate coated with nanometer calcium phosphate as substrate copolymer and coating method thereof | |
| CN110835381A (en) | Composite microsphere with three-layer core-shell structure and preparation method and composite bone cement using the same | |
| TWI526414B (en) | Modified bone cement composition | |
| KR20190126879A (en) | Curable Multi-Part Acrylic Composition | |
| CN111629820B (en) | Hardenable multi-part acrylic composition | |
| CN104307035B (en) | Akermanite/PMMA composite bone cement with induced osteogenesis function and preparation method thereof | |
| CN115645611B (en) | High-strength self-expanding composite bone cement with osteogenic activity and preparation method thereof | |
| CN114984310A (en) | Anti-collapsibility water-swelling organic-inorganic composite bone cement and preparation method thereof | |
| CN119192456A (en) | Acrylate copolymers with different glass transition temperatures, bone cement, and preparation methods and applications thereof | |
| Rusen et al. | Synthesis and characterisation of core–shell structures for orthopaedic surgery | |
| CN121081728A (en) | Magnetic composite bone cement containing CIP@PMMA particles, its preparation method and application | |
| Xie et al. | Synthesis and formulation of zinc-strengthened calcium phosphate polycarboxylate cements |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190528 |
|
| WD01 | Invention patent application deemed withdrawn after publication |